132 related articles for article (PubMed ID: 2186801)
41. Review of management issues in relapsed osteosarcoma.
Vijayamurugan N; Bakhshi S
Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
[TBL] [Abstract][Full Text] [Related]
42. Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period.
Ogunlewe MO; Ajayi OF; Adeyemo WL; Ladeinde AL; James O
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jan; 101(1):76-81. PubMed ID: 16360611
[TBL] [Abstract][Full Text] [Related]
43. The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw.
Bertoni F; Dallera P; Bacchini P; Marchetti C; Campobassi A
Cancer; 1991 Oct; 68(7):1555-63. PubMed ID: 1893357
[TBL] [Abstract][Full Text] [Related]
44. Diseases affecting the jaws. I. Paget's disease, chondrogenic and osteogenic neoplasms.
Rice DH; Batsakis JG; Briere RO
Univ Mich Med Cent J; 1968; 34(3):153-60. PubMed ID: 5243007
[No Abstract] [Full Text] [Related]
45. Expression and significance of hypoxemia-inducible factor-1alpha in osteosarcoma of the jaws.
Chen WL; Feng HJ; Li HG
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):254-7. PubMed ID: 18554951
[TBL] [Abstract][Full Text] [Related]
46. Periosteal osteosarcoma in the hand of a pediatric patient: a case report.
Muir TM; Lehman TP; Meyer WH
J Hand Surg Am; 2008 Feb; 33(2):266-8. PubMed ID: 18294553
[TBL] [Abstract][Full Text] [Related]
47. Clinical and histopathological profile of primary or secondary osteosarcoma of the jaws.
Angiero F; Moltrasio F; Cattoretti G; Valente MG
Anticancer Res; 2011 Dec; 31(12):4485-9. PubMed ID: 22199320
[TBL] [Abstract][Full Text] [Related]
48. A retrospective clinicopathological study of 59 osteogenic sarcoma of jaw bone archived in a stomatology unit.
Ajura AJ; Lau SH
Malays J Pathol; 2010 Jun; 32(1):27-34. PubMed ID: 20614723
[TBL] [Abstract][Full Text] [Related]
49. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
50. [Treatment of primary bone sarcoma of the jaws].
Barthélémy I; Coustal B; Michelet V; Pinsolle J; Siberchicot F; Caix P; Michelet FX
Rev Stomatol Chir Maxillofac; 1994; 95(4):302-5. PubMed ID: 7939361
[TBL] [Abstract][Full Text] [Related]
51. [Expression of parafibromin in human osteosarcoma of the jaws].
Sima ZH; Chen Y; Li TJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):792-6. PubMed ID: 23073595
[TBL] [Abstract][Full Text] [Related]
52. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
53. Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels.
Fujiwara T; Medellin MR; Sambri A; Tsuda Y; Balko J; Sumathi V; Gregory J; Jeys L; Abudu A
Bone Joint J; 2019 Aug; 101-B(8):1024-1031. PubMed ID: 31362545
[TBL] [Abstract][Full Text] [Related]
54. Primary juxtacortical chondrosarcoma dedifferentiating after 20 years.
Kumta SM; Griffith JF; Chow LT; Leung PC
Skeletal Radiol; 1998 Oct; 27(10):569-73. PubMed ID: 9840394
[TBL] [Abstract][Full Text] [Related]
55. Proliferative, apoptotic and angiogenic potentials in jaws and long bones osteosarcomas: a comparative immunohistochemical study.
Jawad SN; Abdullah BH
J Oral Pathol Med; 2010 Oct; 39(9):681-6. PubMed ID: 20701666
[TBL] [Abstract][Full Text] [Related]
56. Osteogenic sarcoma of the jaws in Ibadan, Nigeria.
Daramola JO; Aghadiuno PU; Ajagbe HA; Oluwasanmi JO; Obisesan AA; Lagundoye SB
Br J Oral Surg; 1976 Jul; 14(1):23-30. PubMed ID: 1066152
[No Abstract] [Full Text] [Related]
57. High grade surface osteosarcoma: a clinicopathologic study of 46 cases.
Okada K; Unni KK; Swee RG; Sim FH
Cancer; 1999 Mar; 85(5):1044-54. PubMed ID: 10091787
[TBL] [Abstract][Full Text] [Related]
58. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma.
Laitinen M; Parry M; Albergo JI; Jeys L; Abudu A; Carter S; Sumathi V; Grimer R
Bone Joint J; 2015 Dec; 97-B(12):1698-703. PubMed ID: 26637687
[TBL] [Abstract][Full Text] [Related]
59. Tumours of the jaws.
Gössner W; Luz A
IARC Sci Publ; 1994; (111):141-65. PubMed ID: 8082905
[No Abstract] [Full Text] [Related]
60. [Image analysis of cell nuclear morphology and DNA content in osteosarcoma of the jaws].
Wang L; Wu Q; Sun K
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Mar; 32(2):78-80. PubMed ID: 10677953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
